<code id='97EEE8E573'></code><style id='97EEE8E573'></style>
    • <acronym id='97EEE8E573'></acronym>
      <center id='97EEE8E573'><center id='97EEE8E573'><tfoot id='97EEE8E573'></tfoot></center><abbr id='97EEE8E573'><dir id='97EEE8E573'><tfoot id='97EEE8E573'></tfoot><noframes id='97EEE8E573'>

    • <optgroup id='97EEE8E573'><strike id='97EEE8E573'><sup id='97EEE8E573'></sup></strike><code id='97EEE8E573'></code></optgroup>
        1. <b id='97EEE8E573'><label id='97EEE8E573'><select id='97EEE8E573'><dt id='97EEE8E573'><span id='97EEE8E573'></span></dt></select></label></b><u id='97EEE8E573'></u>
          <i id='97EEE8E573'><strike id='97EEE8E573'><tt id='97EEE8E573'><pre id='97EEE8E573'></pre></tt></strike></i>

          fashion

          fashion

          author:entertainment    Page View:85
          Sammy Kimball for STAT

          Why do CEOs talk like that? Do biotech stock tips make good gifts? And what do Anthony Fauci and Stéphane Bancel have in common?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. First, we discuss why Wall Street was less than convinced by Biogen’s attempt to assuage concerns about its credibility. Then we explain an insider trading scandal that bridges biotech and elite-level soccer, the latest concerns over Wegovy, and the rest of the week’s news in the life sciences. We also break some bittersweet news, with the help of some headline names from around biotech.

          advertisement

          For more on what we cover, here’s the Biogen news; here are the charges against Joe Lewis; here’s the latest on Wegovy; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          explore

          As demand for Covid shots wanes, Moderna seeks its next success
          As demand for Covid shots wanes, Moderna seeks its next success

          RubyWallauforSTATModernachairmanNoubarAfeyanexudedstarpowerearlierthismonthashecommandedthespotlight

          read more
          ‘Oppenheimer’ and the risks of AI in health care
          ‘Oppenheimer’ and the risks of AI in health care

          APAllgreatstorieshavecomplicatedendings.Butthatdoesn’tmeantheycan’toffersimpleandinstructivelessons.

          read more
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum
          New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

          CMSAdministratorChiquitaBrooks-LaSureChipSomodevilla/GettyImagesWASHINGTON— EliLilly’slatestanti-amy

          read more

          Lawsuit alleges UnitedHealth Group unit illegally denied claims

          JimMone/APTheU.S.DepartmentofLaborclaimsinanewlawsuitthataUnitedHealthGroupunitillegallyrejectedemer